Pharmaceutical nanotechnology stands at the forefront of scientific innovation, merging nanoscience and technology to reshape drug development and healthcare interventions. Operating at the nanoscale, it exploits distinctive material properties to finely tune drug formulations, enhancing effectiveness while minimizing adverse effects. This interdisciplinary field not only addresses conventional pharmaceutical challenges but also opens novel avenues for advancements.
Pharmaceutical nanotechnology has also paved the way for personalized medicine. By tailoring drug formulations at the nanoscale, healthcare professionals can optimize treatment regimens based on individual patient characteristics. This level of customization holds great promise for more effective and patient-specific therapies.
Moreover, the diagnostic capabilities of pharmaceutical nanotechnology are remarkable. Nanoscale imaging agents and sensors enable early detection of diseases at the molecular level, allowing for timely interventions and monitoring of treatment responses. This integration of diagnostics and therapeutics is a hallmark of the nanotechnology revolution in pharmaceuticals. As research in this field progresses, addressing these challenges will be crucial to fully realize the potential of nanotechnology in transforming healthcare and pharmaceutical industries.
Pharmaceutical nanotechnology offers a diverse range of applications that redefine drug development, delivery, and diagnostic processes. Some notable applications include:
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil